Data from a human AR positive prostate cancer cell line, LNCaP, reveals that the set of AR and CHD1 interacting proteins overlap considerably, and CHD1-bound enhancer regions are highly concurrent with those bound by the AR (76). This evidence concerns the gene CHD1 and prostate carcinoma.